Probiotics: Nutraceuticals
with a History and a Future
Robert L Clancy University of
Newcastle, Australia
Probiotics as a product of the food industry, are traditionally considered
to be ‘bacteria that are good for
you.’ This wide definition has
become narrowed to one that
considers probiotics to have a
particular local and systemic role
that involves regulation of
mechanisms of mucosal protection. A
more descriptive term is ‘immunobiotics’,
focussing on driving effective
mucosal immunity on one hand, while
downregulating damaging
hypersensitivity reactions, in
particular allergy. The role of the
gut flora in maintaining health has
been recognised for years; probiotic
therapy finds a role in management
when this process is defective. This
presentation will consider some of
the data relevant to mucosal
protection, mechanisms whereby
probiotics modulate immune
mechanisms with a focus on toll-like
receptors, as well as practical
issues regarding isolate selection,
stability and the use of multiple
products. Future directions for
product development and target
disease selection will be discussed